FY20 phase i sbir contract - topic 401 - phase i sbir contract quantitative biomimetic MRI breast tissue and tumor phantom: toward a comprehensive phantom solution for breast cancer diagnostics and…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91020C00056
- Awardee
-
Calibermri, Inc. UEI CK99A8JTWJ15
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,778
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 88% obligated
-
- $399,778.00 Current, with exercised options
- $454,778.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80301, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $399,778 |
About this award
This FY20 Phase I SBIR contract, valued at $454,778, was awarded to Calibermri, Inc. by the National Institutes of Health National Cancer Institute to develop a quantitative biomimetic MRI breast tissue and tumor phantom toward a comprehensive phantom solution for breast cancer diagnostics and treatment monitoring. The contract is a firm fixed price vehicle with a performance period from September 2020 through October 2021 in Boulder, Colorado.
The award is responsive to the National Institutes of Health and Centers for Disease Control and Prevention SBIR solicitation seeking Phase I and Phase II proposals to conduct research and development supporting agency missions in areas including cancer imaging tools and intra-tumor sensing. As a total small business set-aside, the solicitation aims to engage small biotech and medical device firms in research nationwide under the SBIR program.
Description
FY20 phase i sbir contract - topic 401 - phase i sbir contract quantitative biomimetic MRI breast tissue and tumor phantom: toward a comprehensive phantom solution for breast cancer diagnostics and treatment monitoring.
Quick answers
Who was awarded contract 75N91020C00056?
75N91020C00056 was awarded to Calibermri, Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2020.
How much is contract 75N91020C00056 worth?
The government has obligated $399,778 on 75N91020C00056. Its potential value, with all options, is $454,778.
Was contract 75N91020C00056 competed?
The extent of competition for 75N91020C00056 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award